The cash flow of AMPHENOL CORPORATION over the past 10 years
Chart AMPHENOL CORPORATION: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, AMPHENOL CORPORATION's operating cash flow was $5.37B and its capital expenditures $996.6M, leaving free cash flow of $4.38B. Free cash flow was above zero in all 10 years shown. It ranged from $802.1M in fiscal 2018 to $4.38B in fiscal 2025. Capital expenditures were highest in fiscal 2025, at $996.6M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $5.37B | $996.6M | $4.38B |
| 2024ended Dec 31, 2024 | $2.81B | $665.4M | $2.15B |
| 2023ended Dec 31, 2023 | $2.53B | $372.8M | $2.16B |
| 2022ended Dec 31, 2022 | $2.17B | $383.8M | $1.79B |
| 2021ended Dec 31, 2021 | $1.54B | $360.4M | $1.18B |
| 2020ended Dec 31, 2020 | $1.59B | $276.8M | $1.32B |
| 2019ended Dec 31, 2019 | $1.5B | $295M | $1.21B |
| 2018ended Dec 31, 2018 | $1.11B | $310.6M | $802.1M |
| 2017ended Dec 31, 2017 | $1.14B | $226.6M | $917.6M |
| 2016ended Dec 31, 2016 | $1.08B | $190.8M | $886.8M |
Fiscal years as AMPHENOL CORPORATION reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AMPHENOL CORPORATION
- The revenue of AMPHENOL CORPORATION
- The profitability of AMPHENOL CORPORATION
- The debt of AMPHENOL CORPORATION
- The dividends of AMPHENOL CORPORATION
- All of AMPHENOL CORPORATION's financials, charted
Companies of a similar size
- ELVELEVANCE HEALTH, INC.
- INTUINTUIT INC.
- GDGENERAL DYNAMICS CORPORATION
- MRSHMARSH & MCLENNAN COMPANIES, INC.
- WMWASTE MANAGEMENT INC
Not investment advice. This page shows what AMPHENOL CORPORATION filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.